Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients (Q56904424)
Jump to navigation
Jump to search
scientific article published on 01 June 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients |
scientific article published on 01 June 2002 |
Statements
Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients (English)
Ewa Bryl
Piotr Trzonkowski
Bolesław Rutkowski
Jolanta Myśliwska
Andrzej Myśliwski